Exchange: NASDAQ·Updated 07:56 PM EDT
GENE logo

GENE Genetic Technologies Ltd.

$0.765
$0.015
(1.92%)
Today
Closed $0.765
$0.015
(1.96%)
After Hours
Reported EarningsFeb 23
Vol22,667.00

About GENE

Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Maroochydore, Australia.
54

Neutral Sentiment

How do you feel about GENE?

Advertisement|Remove ads.